BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8325105)

  • 1. Expression of lymphocyte activation surface antigens in bronchoalveolar lavage and peripheral blood cells from young healthy subjects.
    Ancochea J; González A; Sánchez MJ; Aspa J; López-Botet M
    Chest; 1993 Jul; 104(1):32-7. PubMed ID: 8325105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
    Wahlström J; Berlin M; Sköld CM; Wigzell H; Eklund A; Grunewald J
    Thorax; 1999 Apr; 54(4):339-46. PubMed ID: 10092696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapy.
    Yacyshyn MB; Poppema S; Berg A; MacLean GD; Reddish MA; Meikle A; Longenecker BM
    Int J Cancer; 1995 May; 61(4):470-4. PubMed ID: 7538976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the expression of lymphocyte activation markers in blood, bronchial biopsies and bronchoalveolar lavage: evidence for an enrichment of activated T lymphocytes in the bronchoalveolar space.
    Ekberg-Jansson A; Arvå E; Nilsson O; Löfdahl CG; Andersson B
    Respir Med; 1999 Aug; 93(8):563-70. PubMed ID: 10542990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High proportion of gamma-delta T cell receptor positive T cells in bronchoalveolar lavage and peripheral blood of HIV-infected patients with Pneumocystis carinii pneumonias.
    Kägi MK; Fierz W; Grob PJ; Russi EW
    Respiration; 1993; 60(3):170-7. PubMed ID: 7692576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expressions of CD69 and HLA-DR but not of CD25 or CD71 on endometrial T lymphocytes of nonpregnant women.
    Chen CK; Huang SC; Chen CL; Yen MR; Hsu HC; Ho HN
    Hum Immunol; 1995 Mar; 42(3):227-32. PubMed ID: 7759310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging.
    Rea IM; McNerlan SE; Alexander HD
    Exp Gerontol; 1999 Jan; 34(1):79-93. PubMed ID: 10197730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased number of activated lymphocytes in human lung following swine dust inhalation.
    Müller-Suur C; Larsson K; Malmberg P; Larsson PH
    Eur Respir J; 1997 Feb; 10(2):376-80. PubMed ID: 9042635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis: antigen expression defect in vitro.
    Giordano C; De Maria R; Todaro M; Stassi G; Mattina A; Richiusa P; Galluzzo G; Pantó F; Galluzzo A
    J Clin Immunol; 1993 Jan; 13(1):68-78. PubMed ID: 8095271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T cells expressing the co-stimulatory receptor NKG2 D are increased in cigarette smoking and COPD.
    Roos-Engstrand E; Pourazar J; Behndig AF; Blomberg A; Bucht A
    Respir Res; 2010 Sep; 11(1):128. PubMed ID: 20863413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of bronchoalveolar lavage T cell subsets in sarcoidosis on the basis of CD57, CD4 and CD8.
    Kurumagawa T; Seki S; Kobayashi H; Koike Y; Kanoh S; Hiraide H; Motoyoshi K
    Clin Exp Immunol; 2003 Sep; 133(3):438-47. PubMed ID: 12930372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytofluorimetric analysis of mitogen-activated peripheral blood lymphocytes of non-leukemic lymphoma patients reveals an abnormal disease-related expression pattern of activation antigens.
    Mangge H; Beaufort F; Kaulfersch W; Rossipal E; Schauenstein K
    J Cancer Res Clin Oncol; 1990; 116(6):575-80. PubMed ID: 2174895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypic characterisation of peripheral blood lymphocytes in autoimmune polyglandular syndrome type 1: clinical study and review of the literature.
    Perniola R; Lobreglio G; Rosatelli MC; Pitotti E; Accogli E; De Rinaldis C
    J Pediatr Endocrinol Metab; 2005 Feb; 18(2):155-64. PubMed ID: 15751604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of flow cytometry in evaluation of cellular changes in interstitial lung diseases].
    Kopiński P
    Folia Med Cracov; 1997; 38(3-4):69-115. PubMed ID: 10481384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma.
    Wilson JW; Djukanović R; Howarth PH; Holgate ST
    Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):958-60. PubMed ID: 1554226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal expression of p55 interleukin 2 receptor (CD25) by lymphocytes from former blood donors seropositive for human T lymphotropic virus.
    Prince HE; Jackson AL
    Clin Immunol Immunopathol; 1990 Dec; 57(3):459-64. PubMed ID: 1700938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ activation of helper T cells in the lung.
    Raju B; Tung CF; Cheng D; Yousefzadeh N; Condos R; Rom WN; Tse DB
    Infect Immun; 2001 Aug; 69(8):4790-8. PubMed ID: 11447152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
    Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
    Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.